Study says peel compounds may reverse damage from some multiple sclerosis

A new study from Thomas Jefferson University has found preliminary evidence that a compound found in some herbs and peels may help protect and reverse some of the damage caused by a devastating autoimmune disease called multiple sclerosis,media reported. Existing treatments for multiple sclerosis can help slow the progression of the disease, but at this point they do not reverse the damage done to neurons.

Study says peel compounds may reverse damage from some multiple sclerosis

Multiple sclerosis is a disease in which the body’s immune system begins to attack protective palates that cover nerves and neurons, leading to sexual pain, numbness, muscle weakness, vision impairment, memory loss, and more. Early interventionmay could slow the progression of the disease, but there is no cure.

The newly published study involved mimicking human progress in mouse models of multiple sclerosis. The researchers focused their research on mice with the disease for a long time, which meant that the central nervous system of these mice was damaged by the disease. On the 60th day of the mice’s illness, purified laboratory-grade bear glastic acid was introduced, which is described as a late stage involving spinal cord and brain damage. On the 20th day of treatment, the 80th day of the mice’s disease, the researchers found that paralysed mice could walk again, even though they still had symptoms of muscle weakness.

This suggests that, in such a late period of time, the damage caused by the disease has been reversed. In addition, the researchers found that bear gallacid may activate precursor cells, leading to the formation of myelin cells in patients with multiple sclerosis that are destroyed by the immune system, which may explain the positive changes observed in mice.

Dr. Zhang Guangxian, co-author of the study, explained.

This is not a treatment, but if we see a similar reaction in people, it will represent a significant change in the quality of life. And most importantly, it’s a reversal, and at such a late stage of the disease, we really haven’t seen any reversal of other drugs.

However, more research is needed to determine whether the compound is safe in high doses and whether it is as effective in humans as in mice, and further research is needed.